Effect of repeated systemic administration of selective inhibitors of endocannabinoid inactivation on rat brain endocannabinoid levels
- 1 August 2005
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 70 (3) , 446-452
- https://doi.org/10.1016/j.bcp.2005.05.011
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Reversible Inhibitors of Fatty Acid Amide Hydrolase That Promote Analgesia: Evidence for an Unprecedented Combination of Potency and SelectivityThe Journal of Pharmacology and Experimental Therapeutics, 2004
- The endocannabinoid system and its therapeutic exploitationNature Reviews Drug Discovery, 2004
- CB1 Cannabinoid Receptors and On-Demand Defense Against ExcitotoxicityScience, 2003
- Cannabinoids inhibit neurodegeneration in models of multiple sclerosisBrain, 2003
- The Endogenous Cannabinoid System Regulates Seizure Frequency and Duration in a Model of Temporal Lobe EpilepsyThe Journal of Pharmacology and Experimental Therapeutics, 2003
- An endogenous cannabinoid tone attenuates cholera toxin-induced fluid accumulation in miceGastroenterology, 2003
- Therapeutic Action of Cannabinoids in a Murine Model of Multiple SclerosisJournal of Neuroscience, 2003
- Modulation of anxiety through blockade of anandamide hydrolysisNature Medicine, 2002
- Experimental Parkinsonism Alters Endocannabinoid Degradation: Implications for Striatal Glutamatergic TransmissionJournal of Neuroscience, 2002
- Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's diseaseSynapse, 2002